REFILE-Eli Lilly to put Loxo executives in charge of new cancer research unit
December 05, 2019 at 06:55 AM EST
U.S. drugmaker Eli Lilly and Co said on Thursday it will create a new cancer research division that will be run by top executives from Loxo Oncology, a cancer-focused biotech company it acquired earlier this year.